Full Coverage

Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for...

                   
drugs.com
May 22, 2008
        
Story Timeline:  198 days

Statistically Significant Reduction of IBS Pain and Normalizing Motility Effect Observed SAN DIEGO, May 20, 2008 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. today announced the results of a recent Phase 2b study of its oral kappa opioid receptor... ... Statistically... [read full story]                    

Add Comment
Latest article on this story:

Asimadoline Positive Results In Irritable Bowel Syndrome Trial

 emaxhealth.com May 23, 2008
First article on this story:

Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for...

 prnewswire.com May 20, 2008
Selected publications with coverage of this story:
prnewswire.com earthtimes.org drugs.com emaxhealth.com pharmiweb.co.uk
RELATED
Found 2 documents:
                   

Asimadoline Positive Results In Irritable Bowel Syndrome Trial

emaxhealth.com
May 23, 2008
        

Tioga Pharmaceuticals announced the results of a recent Phase 2b study of its oral kappa opioid receptor agonist, asimadoline, which demonstrated statistically significant results in the treatment of Irritable Bowel Syndrome (IBS). Asimadoline produced significant improvement in...

                   

Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for...

earthtimes.org
May 20, 2008
        

SAN DIEGO, May 20 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. today announced the results of a recent Phase 2b study of its oral kappa opioid receptor agonist, asimadoline, which demonstrated statistically significant results in the treatment of Irritable Bow...